SCHEMBL4223719

SCHEMBL4223719

CC(=O)Oc1ccccc1-c1c[nH]c2ccccc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 1/20 0.69
PBRM1 Q86U86 1/20 0.53
GSK3B P49841 2/20 0.48
PDE5A O76074 1/20 0.47
LMNA P02545 1/20 0.47
NR4A2 P43354 3/20 0.45
CREBBP Q92793 1/20 0.45
ADK P55263 1/20 0.45
HTT P42858 2/20 0.44
SIRT2 Q8IXJ6 2/20 0.44
SIRT1 Q96EB6 1/20 0.44
ALPL P05186 1/20 0.44
MAPT P10636 1/20 0.44
CDK4 P11802 2/20 0.44
CCND1 P24385 2/20 0.44
PRKD3 O94806 1/20 0.44
CCNB2 O95067 1/20 0.44
CCNE2 O96020 1/20 0.44
ABL1 P00519 1/20 0.44
PRKCG P05129 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28215958 0.83 SLC22A6 (0.48) SLC22A6PBRM1GSK3BLMNANR4A2
Indole Acetate SCHEMBL15553 0.82 SLC22A6 (1.00) SLC22A6PBRM1GSK3BLMNANR4A2
SCHEMBL27790479 0.81 MAPK1 (0.52) SLC22A6PBRM1GSK3BNR4A2CREBBP
Indole Acetate SCHEMBL28825383 0.81 SLC22A6 (0.97) SLC22A6PBRM1GSK3BLMNANR4A2
Indole Acetate SCHEMBL14576593 0.81 SLC22A6 (0.97) SLC22A6PBRM1GSK3BLMNANR4A2
Indole Acetate SCHEMBL14576776 0.81 SLC22A6 (0.97) SLC22A6PBRM1GSK3BLMNANR4A2
SCHEMBL8676653 0.80 PTGS2 (0.61) SLC22A6PDE5ALMNA
SCHEMBL27494000 0.79 PDGFRB (0.51) GSK3BNR4A2SIRT2SIRT1MAPT
SCHEMBL8945241 0.77 KDM4E (0.51) SLC22A6PBRM1LMNAMAPT
Indole Acetate SCHEMBL28648551 0.75 SLC22A6 (0.82) SLC22A6PBRM1LMNANR4A2CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2024371-A1 PHENANTHRENE DERIVATIVES AS MPGES-1 INHIBITORS Merck Frosst Canada Ltd. (CA) 2009-02-18 EP disclosed
WO-2007134434-A1 PHENANTHRENE DERIVATIVES AS MPGES-1 INHIBITORS MERCK FROSST CANADA LTD. (CA) 2007-11-29 WO disclosed